Publications by authors named "Yingcai Feng"

Venetoclax, the first-generation inhibitor of the apoptosis regulator B-cell lymphoma 2 (BCL2), disrupts the interaction between BCL2 and proapoptotic proteins, promoting the apoptosis in malignant cells. Venetoclax is the mainstay of therapy for relapsed chronic lymphocytic leukemia and is under investigation in multiple clinical trials for the treatment of various cancers. Although venetoclax treatment can result in high rates of durable remission, relapse has been widely observed, indicating the emergence of drug resistance.

View Article and Find Full Text PDF
Article Synopsis
  • OX40 is a receptor on activated T cells that, when activated, enhances T cell activation and dendritic cell maturation, making it a target for cancer immunotherapy.
  • While many anti-OX40 antibodies in use compete with OX40L and have limited effectiveness, BGB-A445 is a non-competitive agonistic antibody that enhances T cell activation without affecting dendritic cell function.
  • BGB-A445 has shown significant antitumor effects in studies, outpacing traditional antibodies by also effectively depleting regulatory T cells and demonstrating synergy with anti-PD-1 therapy.
View Article and Find Full Text PDF
Article Synopsis
  • PD-1 is an immune checkpoint receptor targeted in cancer immunotherapy, and tislelizumab is a newly approved anti-PD-1 antibody for specific cancers like Hodgkin's lymphoma and urothelial carcinoma.
  • Recent studies show that tislelizumab has strong antitumor effects in a mouse model and interacts uniquely with PD-1, particularly in a specific region (the CC' loop) that helps it bind effectively.
  • Analyses indicate that tislelizumab binds to PD-1 very tightly and can completely block the interaction with its ligand PD-L1, enhancing our understanding of how anti-PD-1 therapies work.
View Article and Find Full Text PDF

Poly (ADP-ribose) polymerase (PARP) plays a significant role in DNA repair responses; therefore, this enzyme is targeted by PARP inhibitors in cancer therapy. Here we have developed a number of fused tetra- or pentacyclic dihydrodiazepinoindolone derivatives with excellent PARP enzymatic and cellular PARylation inhibition activities. These efforts led to the identification of pamiparib (BGB-290, ), which displays excellent PARP-1 and PARP-2 inhibition with IC of 1.

View Article and Find Full Text PDF

The citrus red mite, , a major citrus pest distributed worldwide, has evolved severe resistance to various classes of chemical acaricides/insecticides including pyrethroids. It is well known that the resistance to pyrethroids is mainly caused by point mutations of voltage-gated sodium channel gene in a wide range of pests. However, increasing number of evidences support that pyrethroids resistance might also be resulted from the integrated mechanisms including metabolic mechanisms.

View Article and Find Full Text PDF

The citrus red mite, Panonychus citri (McGregor), a major citrus pest distributed worldwide, has been found to be resistant to various insecticides and acaricides used in China. However, the molecular mechanisms associated with the abamectin resistance in this species have not yet been reported. In this study, results showed over-expression of a novel glutathione S-transferases (GSTs) gene (PcGSTm5) in abamectin-resistant P.

View Article and Find Full Text PDF

Chitinases are hydrolytic enzymes that are required for chitin degradation and reconstruction in arthropods. In this study, we report a cDNA sequence encoding a putative chitinase (PcCht1) from the citrus red mite, Panonychus citri. The PcCht1 (564 aa) possessed a signal peptide, a conserver domain, and a chitin-binding domain.

View Article and Find Full Text PDF

The regulation of mRNA expression level is critical for gene expression studies. Currently, quantitative reverse transcription polymerase chain reaction (qRT-PCR) is commonly used to investigate mRNA expression level of genes under various experimental conditions. An important factor that determines the optimal quantification of qRT-PCR data is the choice of the reference gene for normalization.

View Article and Find Full Text PDF

Oncogenic BRAF, which drives cell transformation and proliferation, has been detected in approximately 50% of human malignant melanomas and 5% to 15% of colorectal cancers. Despite the remarkable clinical activities achieved by vemurafenib and dabrafenib in treating BRAF(V600E) metastatic melanoma, their clinical efficacy in BRAF(V600E) colorectal cancer is far less impressive. Prior studies suggested that feedback activation of EGFR and MAPK signaling upon BRAF inhibition might contribute to the relative unresponsiveness of colorectal cancer to the first-generation BRAF inhibitors.

View Article and Find Full Text PDF

Superoxide dismutase (SOD) is a family of enzymes with multiple isoforms that possess antioxidative abilities in response to environmental stresses. Panonychus citri is one of the most important pest mites and has a global distribution. In this study, three distinct isoforms of SOD were cloned from P.

View Article and Find Full Text PDF
Article Synopsis
  • - Chlamydia trachomatis, a common cause of sexually transmitted infections, uses a protease called CPAF which degrades host molecules and is crucial for its pathogenicity.
  • - The mature form of CPAF consists of two identical catalytic units, and it remains inactive due to an internal segment that prevents its activation and dimerization.
  • - Activation of CPAF involves a process called trans-autocatalytic cleavage, leading to structural changes that enable its full activity, and this mechanism may open new avenues for developing treatments against Chlamydia.
View Article and Find Full Text PDF

Previous studies have demonstrated that 14-3-3 proteins exist in all the eukaryotic organisms studied; however, studies on the 14-3-3 proteins have not been involved in the halotolerant, unicellular green alga Dunaliella salina so far. In the present study, a cDNA encoding 14-3-3 protein of D. salina was cloned and sequenced by PCR and rapid amplification of cDNA end (RACE) technique based on homologous sequences of the 14-3-3 proteins found in other organisms.

View Article and Find Full Text PDF